PHC’s New R&D Base to Enhance Healthcare Solutions Development Focusing on Cell Therapies and Regenerative Medicine

October 3, 2018
PHC Holdings Corporation

TOKYO, October 3, 2018 ― PHC Corporation (hereafter PHC), a wholly-owned subsidiary of PHC Holdings Corporation (headquarters: Tokyo, Japan) has started research and development activities at Shonan Health Innovation Park*1 (hereafter, Shonan iPark.).

Shonan iPark is one of the R&D facilities of Takeda Pharmaceutical Company Limited (headquarters: Tokyo, Japan), which is open to industry, government, and academia to foster innovation. With various companies participating, it is designed to accelerate ideas and developments utilizing state-of-the-art Life Science technologies and expertise based on pharmaceuticals drug development know-how. PHC will reinforce researching and developing products and solutions focused on cell therapies and regenerative medicine, making use of iPark’s advantages.

PHC offers value-added products and services for its three core businesses—Medical Devices, Healthcare IT, and Life Sciences. Looking at new medical trends including cell therapies and utilizing the open innovation environment offered by Shonan iPark, PHC contributes to realizing next-generation medicine by enhancing healthcare solutions development to meet the needs of researchers, healthcare professionals, and patients.

*1: For further information, please visit

About PHC Holdings Corporation

Incorporated in 2014, PHC Holdings Corporation is a global healthcare company. Its subsidiaries include PHC Corporation and Ascensia Diabetes Care Holdings AG. Committed to its corporate mission, “We contribute to the wellbeing of society through our diligent efforts by creating new value propositions for all the people who wish for better health,” the company develops, manufactures, sells and services medical equipment and solutions through its three core businesses for medical devices, healthcare IT and life sciences. PHC Holdings Corporation group’s consolidated net sales in FY2017 marked 192.6 billion yen with global distribution of products and services for more than 125 countries. PHC Holdings Corporation changed its name from Panasonic Healthcare Holdings Co., Ltd. in April, 2018.
For further information on PHC Holdings Corporation, please visit

Media contact

Corporate Communications Department
PHC Holdings Corporation